US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

12.04

-0.0400-0.33%

Volume:721.03K

Turnover:8.75M

Market Cap:1.65B

PE:-2.34

High:12.51

Open:12.21

Low:11.89

Close:12.08

Loading ...

Overview Company News Filings

Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases

Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (Fcs)

THOMSON REUTERS

Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS)

Arrowhead presents preclinical results on ARO-ALK7

Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity

Arrowhead Pharmaceuticals Price Target Cut to $38.00/Share From $51.00 by B. Riley Securities

B. Riley Adjusts Price Target on Arrowhead Pharmaceuticals to $38 From $51, Keeps Buy Rating

MT Newswires Live

Arrowhead Pharmaceuticals Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Arrowhead Pharmaceuticals: Promising Pipeline Amidst Cautious Financial Outlook Warrants Hold Rating

Arrowhead Pharmaceuticals: Promising Drug Approval and Expanding Pipeline Justify Buy Rating

Stock Track | Arrowhead Pharmaceuticals Plummets 5.08% Intraday on Widening Q1 Losses and Missed Expectations

ARWR: Multiple Catalysts Ahead in 2025…

Zacks Small Cap Research

Arrowhead Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges

Arrowhead Pharmaceuticals Price Target Maintained With a $42.00/Share by RBC Capital

Stock Track | Arrowhead Pharmaceuticals Plunges Over 8% in Pre-market Trading as Disappointing Q1 Earnings Weigh on Stock

Stock Track | Arrowhead Pharmaceuticals Plunges 6.63% in Pre-market Trading as Earnings Disappoint Investors

Arrowhead Pharmaceuticals: Promising Pipeline and Strategic Developments Drive Buy Rating

Arrowhead Pharmaceuticals Inc (ARWR) Q1 2025 Earnings Call Highlights: Strategic Collaborations ...

Arrowhead Pharmaceuticals Reports Q1 2025 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ARWR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARWR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARWR\",,,,,undefined,":{"symbol":"ARWR","market":"US","secType":"STK","nameCN":"Arrowhead Pharmaceuticals","latestPrice":12.04,"timestamp":1745341912842,"preClose":12.08,"halted":0,"volume":721030,"delay":0,"floatShares":119000000,"shares":137317373,"eps":-5.153072,"marketStatus":"Trading","change":-0.04,"latestTime":"04-22 13:12:01 EDT","open":12.21,"high":12.5075,"low":11.89,"amount":8749717.07575,"amplitude":0.051118,"askPrice":12.06,"askSize":434,"bidPrice":12.01,"bidSize":112,"shortable":3,"etf":0,"ttmEps":-5.153072,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":740203200000,"exchange":"NASDAQ","adjPreClose":12.08,"preHourTrading":{"tag":"盘前","latestPrice":12.34,"preClose":12.08,"latestTime":"09:29 EDT","volume":1341,"amount":16472.939211,"timestamp":1745328599999},"postHourTrading":{"tag":"盘后","latestPrice":12.08,"preClose":12.08,"latestTime":"18:20 EDT","volume":47972,"amount":579499.82,"timestamp":1745274021110},"volumeRatio":0.527906,"impliedVol":0.5644,"impliedVolPercentile":0.536},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARWR\",,,,,undefined,":{"symbol":"ARWR","floatShares":119000000,"roa":"-47.71%","roe":"-565.33%","lyrEps":-5.004783,"volumeRatio":0.527906,"shares":137317373,"dividePrice":0,"high":12.5075,"amplitude":0.051118,"preClose":12.08,"low":11.89,"week52Low":9.57,"pbRate":"31.44","psRate":"661.32","week52High":30.41,"institutionHeld":0.9542,"latestPrice":12.04,"committee":-0.589744,"eps":-5.153072,"divideRate":0,"volume":721030,"delay":0,"ttmEps":-5.153072,"open":12.21,"prevYearClose":18.8,"prevWeekClose":11.24,"prevMonthClose":12.74,"prevQuarterClose":12.74,"fiveDayClose":12.34,"twentyDayClose":15.5,"sixtyDayClose":20.76},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARWR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517716889","title":"Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2517716889","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517716889?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:45","pubTimestamp":1741268700,"startTime":"0","endTime":"0","summary":"- ARO-INHBE and ARO-ALK7 both target a known pathway that signals the body to store fat in adipose tissue with a novel mechanism of action that may better preserve lean muscle mass compared to currently approved obesity therapies. - Data highlight Arrowhead’s leadership in the use of RNA interference to potentially treat Obesity. DIO mice treated with an ALK7 siRNA exhibit a 39% suppression in body weight gain relative to controls. Adipose ALK7 silencing reduced fat mass by 50% while preserving lean mass. Similar to INHBE silencing in hepatocytes, ALK7 silencing in adipocytes enhanced catecholamine sensitivity, increasing lipid mobilization and oxidation, which was not associated with liver","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-showcases-two-clinical-134500669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","SSI","BK4585","BK4588","ARWR"],"gpt_icon":0},{"id":"2514229263","title":"Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (Fcs)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514229263","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514229263?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:00","pubTimestamp":1740751201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUA42KS62:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARWR","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2514327974","title":"Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514327974","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514327974?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:00","pubTimestamp":1740751200,"startTime":"0","endTime":"0","summary":"New Patient Resource Hub: Arrowhead expands its We’ll Get There Soon campaign with the launch of a dedicated patient website, providing education, tools, and support for those living with FCS and extremely high triglycerides. Amplifying Patient Voices: The Spotlight on FCS white paper shares real patient experiences, highlighting the challenges of managing this ultra-rare disease and the need for greater awareness. Commitment to the FCS Community: On Rare Disease Day and beyond, Arrowhead remains dedicated to elevating patient voices and fostering community engagement. #ForFCS. PASADENA, Calif., February 28, 2025----Arrowhead Pharmaceuticals, Inc.  marks Rare Disease Day with the expansion of the We’ll Get There Soon campaign, initially launched for healthcare providers in November 2024. This new phase introduces a dedicated educational website, www.LowerMyTGs.com, and the Spotlight on FCS white paper, which provides essential resources and support for those affected by Familial Chylom","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-launches-rare-disease-140000788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4090","BK4585","ARWR","BK4153","BK4588","TG"],"gpt_icon":0},{"id":"2514099545","title":"Arrowhead presents preclinical results on ARO-ALK7","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099545","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514099545?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:01","pubTimestamp":1740488474,"startTime":"0","endTime":"0","summary":"Arrowhead (ARWR) announced preclinical results on ARO-ALK7, the company’s investigational RNA interference therapeutic targeting Activin receptor-l...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arrowhead-presents-preclinical-results-on-aro-alk7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arrowhead-presents-preclinical-results-on-aro-alk7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","RNA","BK4585","ARWR","BK4505"],"gpt_icon":0},{"id":"2514095256","title":"Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2514095256","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514095256?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:30","pubTimestamp":1740486600,"startTime":"0","endTime":"0","summary":"PASADENA, Calif., February 25, 2025----Arrowhead Pharmaceuticals, Inc.  today announced preclinical results on ARO-ALK7, the company’s investigational RNA interference  therapeutic targeting Activin receptor-like kinase 7  being developed as a potential treatment for obesity. The results were presented in a poster at the Keystone Symposia on Obesity and Adipose Tissue held February 23–26, 2025 in Banff, AB, Canada.ARO-ALK7 is the first RNAi-based therapy to directly target a gene expressed in adipose tissue and highlights Arrowhead’s leadership in the delivery of siRNA to multiple tissues and cell types throughout the body utilizing its proprietary and differentiated Targeted RNAi Molecule  platform. Arrowhead received regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-ALK7 in New Zealand, which the company anticipates will begin dosing in the second quarter of 2025.Single subcutaneous doses of ARO-ALK7 led to dose-dependent and durable reductions in ALK7 mRNA in abdom","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-presents-preclinical-data-123000962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARWR","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2511613486","title":"Arrowhead Pharmaceuticals Price Target Cut to $38.00/Share From $51.00 by B. Riley Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2511613486","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511613486?lang=en_us&edition=fundamental","pubTime":"2025-02-15 01:50","pubTimestamp":1739555400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARWR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 14, 2025 12:50 ET (17:50 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR","RILY"],"gpt_icon":0},{"id":"2511698681","title":"B. Riley Adjusts Price Target on Arrowhead Pharmaceuticals to $38 From $51, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2511698681","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511698681?lang=en_us&edition=fundamental","pubTime":"2025-02-14 21:33","pubTimestamp":1739540015,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals (ARWR) has an average rating of overweight and mean price target of $41.42, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resear","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARWR","RILY"],"gpt_icon":0},{"id":"2511517177","title":"Arrowhead Pharmaceuticals Price Target Maintained With a $80.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2511517177","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511517177?lang=en_us&edition=fundamental","pubTime":"2025-02-13 18:11","pubTimestamp":1739441460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARWR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 13, 2025 05:11 ET (10:11 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR"],"gpt_icon":0},{"id":"2511629835","title":"Arrowhead Pharmaceuticals: Promising Pipeline Amidst Cautious Financial Outlook Warrants Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2511629835","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511629835?lang=en_us&edition=fundamental","pubTime":"2025-02-13 13:39","pubTimestamp":1739425169,"startTime":"0","endTime":"0","summary":"Analyst Mani Foroohar of Leerink Partners maintained a Hold rating on Arrowhead Pharmaceuticals (ARWR – Research Report), retaining the price targe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arrowhead-pharmaceuticals-promising-pipeline-amidst-cautious-financial-outlook-warrants-hold-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arrowhead-pharmaceuticals-promising-pipeline-amidst-cautious-financial-outlook-warrants-hold-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARWR"],"gpt_icon":0},{"id":"2511307910","title":"Arrowhead Pharmaceuticals: Promising Drug Approval and Expanding Pipeline Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2511307910","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511307910?lang=en_us&edition=fundamental","pubTime":"2025-02-13 01:05","pubTimestamp":1739379926,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Arrowhead Pharmaceuticals (ARWR – Research Report) today and set a price target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arrowhead-pharmaceuticals-promising-drug-approval-and-expanding-pipeline-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arrowhead-pharmaceuticals-promising-drug-approval-and-expanding-pipeline-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARWR"],"gpt_icon":0},{"id":"1120725347","title":"Stock Track | Arrowhead Pharmaceuticals Plummets 5.08% Intraday on Widening Q1 Losses and Missed Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1120725347","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120725347?lang=en_us&edition=fundamental","pubTime":"2025-02-12 23:02","pubTimestamp":1739372539,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals, a biopharmaceutical company focused on developing targeted RNA interference  therapeutics, saw its stock plummet 5.08% in Wednesday's intraday trading session. This significant decline followed the company's disappointing first-quarter 2025 earnings report, which missed analysts' expectations and showcased widening losses.The key financial highlights from the report were:. Net loss of $173.1 million, a 30% increase from the same quarter last year. Earnings per share lo","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Arrowhead Pharmaceuticals Plummets 5.08% Intraday on Widening Q1 Losses and Missed Expectations","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ARWR"],"gpt_icon":0},{"id":"2511958135","title":"ARWR: Multiple Catalysts Ahead in 2025…","url":"https://stock-news.laohu8.com/highlight/detail?id=2511958135","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511958135?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:22","pubTimestamp":1739370120,"startTime":"0","endTime":"0","summary":"On January 17, 2025, Arrowhead Pharmaceuticals, Inc.  announced that the U.S. Food and Drug Administration  accepted the New Drug Application  for plozasiran for the treatment of familial chylomycronemia syndrome , with a Prescription Drug User Fee Act  action date of November 18, 2025. The agency also indicated that it did not currently plan to hold an advisory committee meeting. We anticipate the company submitting additional applications for approval of plozasiran for the treatment of FCS with other regulatory agencies in 2025.The NDA is based in part on the successful Phase 3 PALISADE trial, the results of which were recently published in The New England Journal of Medicine . The trial met its primary endpoint and showed that treatment with plozasiran led to a median change from baseline of 80% in fasting triglycerides along with a statistically significant 83% reduction in the risk of developing acute pancreatitis compared to placebo.The company has initiated a Phase 1/2a trial of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arwr-multiple-catalysts-ahead-2025-142200380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARWR","BK4588","BK4135","CNS","BK4139","BK4585"],"gpt_icon":0},{"id":"2510327377","title":"Arrowhead Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2510327377","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510327377?lang=en_us&edition=fundamental","pubTime":"2025-02-12 18:58","pubTimestamp":1739357899,"startTime":"0","endTime":"0","summary":"NasdaqGS:ARWR Earnings and Revenue Growth February 12th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 87%. Earnings per share  also missed analyst estimates significantly.Looking ahead, revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's shares are down 4.0% from a week ago.Before you take the next step you should know about the 5 warning signs for Arrowhead Pharmaceuticals that we have uncovered.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-first-quarter-2025-105819431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARWR"],"gpt_icon":0},{"id":"2510362599","title":"Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2510362599","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510362599?lang=en_us&edition=fundamental","pubTime":"2025-02-12 08:03","pubTimestamp":1739318599,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals, Inc. (($ARWR)) has held its Q1 earnings call. Read on for the main highlights of the call. Arrowhead Pharmaceuticals’ re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arrowhead-pharmaceuticals-earnings-call-highlights-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arrowhead-pharmaceuticals-earnings-call-highlights-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARWR"],"gpt_icon":0},{"id":"2510337294","title":"Arrowhead Pharmaceuticals Price Target Maintained With a $42.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2510337294","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510337294?lang=en_us&edition=fundamental","pubTime":"2025-02-12 01:17","pubTimestamp":1739294220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARWR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2025 12:17 ET (17:17 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR"],"gpt_icon":0},{"id":"1155114731","title":"Stock Track | Arrowhead Pharmaceuticals Plunges Over 8% in Pre-market Trading as Disappointing Q1 Earnings Weigh on Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1155114731","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155114731?lang=en_us&edition=fundamental","pubTime":"2025-02-11 22:36","pubTimestamp":1739284616,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals  stock plummeted over 8% in pre-market trading on Tuesday, following the release of its fiscal Q1 2025 earnings results. The biopharmaceutical company reported a widening net loss and declining revenue, raising concerns among investors about its financial performance.Arrowhead's net loss for the quarter expanded significantly to $173.1 million or $1.39 per share, compared to a net loss of $132.9 million in the prior-year period. Additionally, the company's revenue decli","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ARWR"],"gpt_icon":0},{"id":"1103852588","title":"Stock Track | Arrowhead Pharmaceuticals Plunges 6.63% in Pre-market Trading as Earnings Disappoint Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=1103852588","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103852588?lang=en_us&edition=fundamental","pubTime":"2025-02-11 22:08","pubTimestamp":1739282900,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals  stock plummeted 6.63% in pre-market trading on Tuesday, following the release of its disappointing fiscal Q1 2025 earnings results.While the company reported positive developments such as a significant collaboration agreement with Sarepta Therapeutics and a strong potential catalyst calendar for 2025, investors were likely concerned about the following factors:. Net loss widened to $173.1 million or $1.39 per share for the quarter, compared to a net loss of $132.9 mill","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Arrowhead Pharmaceuticals Plunges 6.63% in Pre-market Trading as Earnings Disappoint Investors","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ARWR"],"gpt_icon":0},{"id":"2510806811","title":"Arrowhead Pharmaceuticals: Promising Pipeline and Strategic Developments Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2510806811","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510806811?lang=en_us&edition=fundamental","pubTime":"2025-02-11 18:07","pubTimestamp":1739268460,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Jason Gerberry has reiterated their bullish stance on ARWR stock, giving a Buy rating yesterday. Jason Gerberry ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arrowhead-pharmaceuticals-promising-pipeline-and-strategic-developments-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arrowhead-pharmaceuticals-promising-pipeline-and-strategic-developments-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARWR"],"gpt_icon":0},{"id":"2510987371","title":"Arrowhead Pharmaceuticals Inc (ARWR) Q1 2025 Earnings Call Highlights: Strategic Collaborations ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2510987371","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510987371?lang=en_us&edition=fundamental","pubTime":"2025-02-11 15:06","pubTimestamp":1739257607,"startTime":"0","endTime":"0","summary":"Net Loss: $173.1 million or $1.39 per share for the quarter ended December 31, 2024.Revenue: $2.5 million for the quarter ended December 31, 2024.Total Operating Expenses: $163.9 million for the quarter ended December 31, 2024.Cash and Investments: $552.9 million at December 31, 2024; pro forma cash and investments would be $1.4 billion including Sarepta payments.GuruFocus has detected 5 Warning Signs with ARWR.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Arrowhead Pharmaceuticals Inc  closed a significant license and collaboration agreement with Sarepta Therapeutics, expected to bring in $1.375 billion in cash payments.The company is now funded into 2028, with potential for multiple commercial launches by Arrowhead and its partners.Arrowhead Pharmaceuticals Inc  reported a net loss of $173.1 million for the quarter ended December 31, 2024, compared to a net loss of $132.9 million in the previous year.Arrowhead Pharmaceuticals Inc ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-inc-arwr-q1-070647026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARWR"],"gpt_icon":0},{"id":"2510823313","title":"Arrowhead Pharmaceuticals Reports Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2510823313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510823313?lang=en_us&edition=fundamental","pubTime":"2025-02-11 11:53","pubTimestamp":1739245990,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals, Inc. ( ($ARWR) ) has released its Q1 earnings. Here is a breakdown of the information Arrowhead Pharmaceuticals, Inc. pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arrowhead-pharmaceuticals-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arrowhead-pharmaceuticals-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARWR","BK4588","BK4585","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":134,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARWR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-10","symbol":"ARWR","fiscalQuarterEnding":"2024/12","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739163600000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2024-11-26","symbol":"ARWR","fiscalQuarterEnding":"2024/09","expectedEps":-0.63,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1732597200000,"reportTimeType":"post","actualEps":-1.38},{"market":"US","date":"2024-08-08","symbol":"ARWR","fiscalQuarterEnding":"2024/06","expectedEps":-0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-1.38},{"market":"US","date":"2024-05-09","symbol":"ARWR","fiscalQuarterEnding":"2024/03","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-1.02},{"market":"US","date":"2024-02-06","symbol":"ARWR","fiscalQuarterEnding":"2023/12","expectedEps":-0.78,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707195600000,"reportTimeType":"post","actualEps":-1.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARWR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARWR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1333,"buy":0.5333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5333,"analysts":15,"updateTime":1717819200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARWR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARWR","date":"2025-04-21","current":-2.215588,"percent":0.936118,"low":-296.588514,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"high":547.43255,"avg":-17.905558,"sd":115.567012,"marketCap":1417342767},"quantilePoints":[{"date":"2020-04-24","current":74.220832,"twenty":-18.275409,"median":-4.206053,"eighty":-1.052527,"marketCap":3953342610},{"date":"2020-05-01","current":62.140146,"twenty":-18.275409,"median":-4.153652,"eighty":-1.026185,"marketCap":3309869771},{"date":"2020-05-08","current":364.527936,"twenty":-18.275409,"median":-4.13929,"eighty":41.608706,"marketCap":3474539574},{"date":"2020-05-15","current":382.786365,"twenty":-18.275409,"median":-4.132262,"eighty":49.925866,"marketCap":3648571872},{"date":"2020-05-22","current":381.077974,"twenty":-18.275409,"median":-4.111179,"eighty":53.834436,"marketCap":3632288149},{"date":"2020-05-29","current":344.240792,"twenty":-18.275409,"median":-4.077636,"eighty":55.242895,"marketCap":3281170353},{"date":"2020-06-05","current":363.780515,"twenty":-18.275409,"median":-4.040903,"eighty":57.04414,"marketCap":3467415445},{"date":"2020-06-12","current":349.47274,"twenty":-18.275409,"median":-4.02418,"eighty":58.828247,"marketCap":3331039258},{"date":"2020-06-19","current":392.182515,"twenty":-18.275409,"median":-3.992874,"eighty":60.10843,"marketCap":3738132354},{"date":"2020-06-26","current":462.012999,"twenty":-18.275409,"median":-3.957597,"eighty":60.495173,"marketCap":4403729565},{"date":"2020-07-02","current":471.943021,"twenty":-18.275409,"median":-3.92846,"eighty":61.039647,"marketCap":4498378710},{"date":"2020-07-10","current":475.253029,"twenty":-18.275409,"median":-3.891958,"eighty":61.895529,"marketCap":4529928425},{"date":"2020-07-17","current":523.408301,"twenty":-18.275409,"median":-3.871005,"eighty":62.625798,"marketCap":4988925891},{"date":"2020-07-24","current":493.404684,"twenty":-18.275409,"median":-3.843641,"eighty":64.1913,"marketCap":4702942991},{"date":"2020-07-31","current":459.87751,"twenty":-18.275409,"median":-3.801907,"eighty":65.132645,"marketCap":4383374911},{"date":"2020-08-07","current":-168.551432,"twenty":-18.529695,"median":-3.789176,"eighty":65.318147,"marketCap":4115199234},{"date":"2020-08-14","current":-176.00909,"twenty":-18.968112,"median":-3.789176,"eighty":65.318147,"marketCap":4297278644},{"date":"2020-08-21","current":-178.020143,"twenty":-19.299259,"median":-3.789176,"eighty":65.318147,"marketCap":4346378709},{"date":"2020-08-28","current":-175.841502,"twenty":-19.749926,"median":-3.789176,"eighty":65.318147,"marketCap":4293186971},{"date":"2020-09-04","current":-150.99661,"twenty":-20.156605,"median":-3.789176,"eighty":65.318147,"marketCap":3686596580},{"date":"2020-09-11","current":-139.139773,"twenty":-20.285462,"median":-3.789176,"eighty":65.318147,"marketCap":3397110777},{"date":"2020-09-18","current":-180.575857,"twenty":-20.45098,"median":-3.789176,"eighty":65.318147,"marketCap":4408776709},{"date":"2020-09-25","current":-188.180154,"twenty":-20.855341,"median":-3.789176,"eighty":65.318147,"marketCap":4594436331},{"date":"2020-10-02","current":-183.592438,"twenty":-21.000912,"median":-3.789176,"eighty":65.318147,"marketCap":4482426807},{"date":"2020-10-09","current":-192.935458,"twenty":-21.181622,"median":-3.789176,"eighty":65.318147,"marketCap":4710537528},{"date":"2020-10-16","current":-206.887142,"twenty":-21.519563,"median":-3.789176,"eighty":65.318147,"marketCap":5051169232},{"date":"2020-10-23","current":-246.689245,"twenty":-21.724568,"median":-3.789176,"eighty":65.318147,"marketCap":6022941360},{"date":"2020-10-30","current":-240.069527,"twenty":-21.896478,"median":-3.789176,"eighty":65.318147,"marketCap":5861320311},{"date":"2020-11-06","current":-278.405237,"twenty":-22.1947,"median":-3.789176,"eighty":65.318147,"marketCap":6797290309},{"date":"2020-11-13","current":-287.1617,"twenty":-22.423055,"median":-3.789176,"eighty":65.318147,"marketCap":7011080177},{"date":"2020-11-20","current":-288.25102,"twenty":-22.812061,"median":-3.789176,"eighty":65.318147,"marketCap":7037676046},{"date":"2020-11-27","current":-76.551382,"twenty":-23.016886,"median":-3.789176,"eighty":65.318147,"marketCap":6472649005},{"date":"2020-12-04","current":-79.346559,"twenty":-23.27504,"median":-3.789176,"eighty":65.318147,"marketCap":6708989578},{"date":"2020-12-11","current":-90.004689,"twenty":-23.443255,"median":-3.789176,"eighty":65.318147,"marketCap":7610166460},{"date":"2020-12-18","current":-97.417984,"twenty":-23.662829,"median":-3.789176,"eighty":65.318147,"marketCap":8236982763},{"date":"2020-12-24","current":-102.315619,"twenty":-23.828206,"median":-3.789176,"eighty":65.318147,"marketCap":8651092550},{"date":"2020-12-31","current":-93.249524,"twenty":-23.877135,"median":-3.789176,"eighty":65.318147,"marketCap":7884527038},{"date":"2021-01-08","current":-97.077701,"twenty":-23.97186,"median":-3.789176,"eighty":65.318147,"marketCap":8208210867},{"date":"2021-01-15","current":-98.122854,"twenty":-24.454235,"median":-3.789176,"eighty":65.318147,"marketCap":8296581690},{"date":"2021-01-22","current":-99.739195,"twenty":-24.744147,"median":-3.789176,"eighty":65.318147,"marketCap":8433248195},{"date":"2021-01-29","current":-94.726725,"twenty":-24.828261,"median":-3.789176,"eighty":65.318147,"marketCap":8009428769},{"date":"2021-02-05","current":-91.510733,"twenty":-25.440997,"median":-3.789176,"eighty":65.318147,"marketCap":9390099332},{"date":"2021-02-12","current":-89.21462,"twenty":-26.042831,"median":-3.805477,"eighty":65.318147,"marketCap":9154490562},{"date":"2021-02-19","current":-90.53969,"twenty":-26.322299,"median":-3.843641,"eighty":65.318147,"marketCap":9290458619},{"date":"2021-02-26","current":-80.576379,"twenty":-26.916244,"median":-3.873833,"eighty":65.318147,"marketCap":8268103380},{"date":"2021-03-05","current":-69.79375,"twenty":-28.366158,"median":-3.907377,"eighty":65.320437,"marketCap":7161676290},{"date":"2021-03-12","current":-73.576774,"twenty":-29.531319,"median":-3.935488,"eighty":65.320437,"marketCap":7549859903},{"date":"2021-03-19","current":-68.175344,"twenty":-30.12048,"median":-3.970626,"eighty":65.320437,"marketCap":6995608434},{"date":"2021-03-26","current":-63.674153,"twenty":-30.547075,"median":-3.999327,"eighty":65.318147,"marketCap":6533732209},{"date":"2021-04-01","current":-67.841548,"twenty":-30.954671,"median":-4.016306,"eighty":65.318147,"marketCap":6961356938},{"date":"2021-04-09","current":-62.86495,"twenty":-31.342858,"median":-4.012792,"eighty":65.320437,"marketCap":6450698281},{"date":"2021-04-16","current":-68.42822,"twenty":-31.889554,"median":-4.012792,"eighty":65.320437,"marketCap":7021556536},{"date":"2021-04-23","current":-72.413545,"twenty":-32.415644,"median":-4.012792,"eighty":65.320437,"marketCap":7430498631},{"date":"2021-04-30","current":-73.597004,"twenty":-32.808234,"median":-4.012792,"eighty":65.320437,"marketCap":7551935751},{"date":"2021-05-07","current":-63.043178,"twenty":-45.932572,"median":-4.012792,"eighty":65.320437,"marketCap":6909154068},{"date":"2021-05-14","current":-69.168946,"twenty":-56.438632,"median":-4.033875,"eighty":65.320437,"marketCap":7580501519},{"date":"2021-05-21","current":-70.498571,"twenty":-57.863948,"median":-4.083069,"eighty":65.320437,"marketCap":7726220345},{"date":"2021-05-28","current":-68.950508,"twenty":-58.296058,"median":-4.111179,"eighty":65.320437,"marketCap":7556561997},{"date":"2021-06-04","current":-72.312558,"twenty":-58.476641,"median":-4.111179,"eighty":65.320437,"marketCap":7925022458},{"date":"2021-06-11","current":-84.250683,"twenty":-59.153827,"median":-4.111179,"eighty":65.320437,"marketCap":9233369349},{"date":"2021-06-18","current":-81.335007,"twenty":-59.54079,"median":-4.132262,"eighty":65.320437,"marketCap":8913828780},{"date":"2021-06-25","current":-85.779751,"twenty":-60.082539,"median":-4.188484,"eighty":65.320437,"marketCap":9400946000},{"date":"2021-07-02","current":-59.956551,"twenty":-60.959657,"median":-4.346124,"eighty":65.320437,"marketCap":6570878221},{"date":"2021-07-09","current":-63.764974,"twenty":-61.333721,"median":-4.547082,"eighty":65.320437,"marketCap":6988258574},{"date":"2021-07-16","current":-60.24147,"twenty":-61.430462,"median":-4.684632,"eighty":65.320437,"marketCap":6602103684},{"date":"2021-07-23","current":-64.933144,"twenty":-61.694887,"median":-4.836997,"eighty":65.320437,"marketCap":7116282972},{"date":"2021-07-30","current":-65.806897,"twenty":-62.139895,"median":-5.073506,"eighty":65.320437,"marketCap":7212041058},{"date":"2021-08-06","current":-53.65037,"twenty":-62.324426,"median":-5.25661,"eighty":65.320437,"marketCap":6754957196},{"date":"2021-08-13","current":-50.11453,"twenty":-62.324426,"median":-5.302386,"eighty":65.320437,"marketCap":6309770173},{"date":"2021-08-20","current":-49.625972,"twenty":-62.324426,"median":-5.37105,"eighty":65.320437,"marketCap":6248257212},{"date":"2021-08-27","current":-54.710294,"twenty":-62.324426,"median":-5.386309,"eighty":65.320437,"marketCap":6888409043},{"date":"2021-09-03","current":-55.935832,"twenty":-62.324426,"median":-5.401568,"eighty":65.320437,"marketCap":7042712742},{"date":"2021-09-10","current":-52.987918,"twenty":-62.324426,"median":-5.401568,"eighty":65.320437,"marketCap":6671549791},{"date":"2021-09-17","current":-53.7663,"twenty":-62.324426,"median":-5.500749,"eighty":65.320437,"marketCap":6769553492},{"date":"2021-09-24","current":-54.130649,"twenty":-62.324426,"median":-5.561784,"eighty":65.320437,"marketCap":6815427564},{"date":"2021-10-01","current":-51.836907,"twenty":-62.324426,"median":-9.576545,"eighty":65.320437,"marketCap":6526629425},{"date":"2021-10-08","current":-49.957198,"twenty":-62.324426,"median":-10.599494,"eighty":65.320437,"marketCap":6289960914},{"date":"2021-10-15","current":-54.78482,"twenty":-62.324426,"median":-12.617221,"eighty":65.320437,"marketCap":6897792376},{"date":"2021-10-22","current":-54.677172,"twenty":-62.324426,"median":-13.619752,"eighty":65.320437,"marketCap":6884238673},{"date":"2021-10-29","current":-52.847147,"twenty":-62.324426,"median":-14.182147,"eighty":65.320437,"marketCap":6653825717},{"date":"2021-11-05","current":-66.849736,"twenty":-62.691778,"median":-14.893608,"eighty":65.320437,"marketCap":8416849736},{"date":"2021-11-12","current":-61.227171,"twenty":-62.849328,"median":-15.49945,"eighty":65.320437,"marketCap":7708929388},{"date":"2021-11-19","current":-58.883745,"twenty":-62.849328,"median":-15.600362,"eighty":65.320437,"marketCap":7413875694},{"date":"2021-11-26","current":-53.447273,"twenty":-62.849328,"median":-15.768963,"eighty":65.320437,"marketCap":7527941490},{"date":"2021-12-03","current":-50.092904,"twenty":-62.849328,"median":-16.040498,"eighty":65.320437,"marketCap":7055485290},{"date":"2021-12-10","current":-52.000145,"twenty":-62.849328,"median":-16.358374,"eighty":65.320437,"marketCap":7324116359},{"date":"2021-12-17","current":-51.695877,"twenty":-62.849328,"median":-16.725153,"eighty":65.320437,"marketCap":7281260819},{"date":"2021-12-23","current":-52.133726,"twenty":-62.849328,"median":-16.774057,"eighty":65.320437,"marketCap":7342930987},{"date":"2021-12-31","current":-49.202363,"twenty":-62.849328,"median":-17.043029,"eighty":65.320437,"marketCap":6930054440},{"date":"2022-01-07","current":-43.747802,"twenty":-62.849328,"median":-17.532069,"eighty":65.318147,"marketCap":6161790486},{"date":"2022-01-14","current":-42.901789,"twenty":-62.849328,"median":-17.703232,"eighty":65.318147,"marketCap":6042631179},{"date":"2022-01-21","current":-37.729233,"twenty":-62.849328,"median":-17.9233,"eighty":65.318147,"marketCap":5314086994},{"date":"2022-01-28","current":-37.50079,"twenty":-62.849328,"median":-18.094464,"eighty":65.318147,"marketCap":5281911207},{"date":"2022-02-04","current":-28.67194,"twenty":-62.849328,"median":-18.47347,"eighty":65.318147,"marketCap":5246620871},{"date":"2022-02-11","current":-29.190628,"twenty":-62.849328,"median":-18.89431,"eighty":65.318147,"marketCap":5341534615},{"date":"2022-02-18","current":-25.502177,"twenty":-62.849328,"median":-19.299259,"eighty":65.318147,"marketCap":4666592433},{"date":"2022-02-25","current":-25.352334,"twenty":-62.849328,"median":-19.511471,"eighty":65.318147,"marketCap":4639172906},{"date":"2022-03-04","current":-24.735671,"twenty":-62.849328,"median":-19.873469,"eighty":65.318147,"marketCap":4526331010},{"date":"2022-03-11","current":-24.078666,"twenty":-62.849328,"median":-20.265536,"eighty":65.318147,"marketCap":4406106934},{"date":"2022-03-18","current":-27.30606,"twenty":-62.849328,"median":-20.427007,"eighty":65.318147,"marketCap":4996681344},{"date":"2022-03-25","current":-25.421493,"twenty":-62.849328,"median":-20.792261,"eighty":65.318147,"marketCap":4651828072},{"date":"2022-04-01","current":-28.354963,"twenty":-62.849328,"median":-20.994442,"eighty":65.318147,"marketCap":5188618027},{"date":"2022-04-08","current":-27.807459,"twenty":-62.849328,"median":-21.14622,"eighty":65.318147,"marketCap":5088431297},{"date":"2022-04-14","current":-27.012137,"twenty":-62.849328,"median":-21.291767,"eighty":65.318147,"marketCap":4942896888},{"date":"2022-04-22","current":-24.585828,"twenty":-62.849328,"median":-21.677169,"eighty":65.318147,"marketCap":4498911484},{"date":"2022-04-29","current":-23.692531,"twenty":-62.849328,"median":-21.85137,"eighty":65.318147,"marketCap":4335448924},{"date":"2022-05-06","current":-21.277749,"twenty":-62.849328,"median":-22.070043,"eighty":65.318147,"marketCap":3893572714},{"date":"2022-05-13","current":-29.922841,"twenty":-62.849328,"median":-22.230837,"eighty":65.318147,"marketCap":3345493368},{"date":"2022-05-20","current":-34.24482,"twenty":-62.849328,"median":-22.60735,"eighty":65.318147,"marketCap":3828707802},{"date":"2022-05-27","current":-32.343906,"twenty":-62.849328,"median":-22.835097,"eighty":65.318147,"marketCap":3616178040},{"date":"2022-06-03","current":-32.968086,"twenty":-62.849328,"median":-23.022811,"eighty":65.318147,"marketCap":3685963932},{"date":"2022-06-10","current":-28.863626,"twenty":-62.849328,"median":-23.265009,"eighty":65.318147,"marketCap":3227068824},{"date":"2022-06-17","current":-27.539606,"twenty":-62.849328,"median":-23.436785,"eighty":65.318147,"marketCap":3079038144},{"date":"2022-06-24","current":-32.589795,"twenty":-62.849328,"median":-23.562992,"eighty":65.320437,"marketCap":3643669452},{"date":"2022-07-01","current":-34.008387,"twenty":-62.849328,"median":-23.735995,"eighty":65.320437,"marketCap":3802273752},{"date":"2022-07-08","current":-39.465239,"twenty":-62.849328,"median":-23.824971,"eighty":65.320437,"marketCap":4412371626},{"date":"2022-07-15","current":-40.477169,"twenty":-62.849328,"median":-23.891697,"eighty":65.320437,"marketCap":4525509360},{"date":"2022-07-22","current":-40.354224,"twenty":-62.849328,"median":-23.943598,"eighty":65.320437,"marketCap":4511763654},{"date":"2022-07-29","current":-40.221822,"twenty":-62.849328,"median":-24.254281,"eighty":65.320437,"marketCap":4496960586},{"date":"2022-08-05","current":-31.604916,"twenty":-62.849328,"median":-24.559153,"eighty":65.320437,"marketCap":4864818339},{"date":"2022-08-12","current":-32.519506,"twenty":-62.849328,"median":-24.631934,"eighty":65.320437,"marketCap":5005597460},{"date":"2022-08-19","current":-29.301251,"twenty":-62.849328,"median":-24.78754,"eighty":65.320437,"marketCap":4510224313},{"date":"2022-08-26","current":-27.547714,"twenty":-62.849328,"median":-24.830151,"eighty":65.320437,"marketCap":4240309457},{"date":"2022-09-02","current":-27.107611,"twenty":-62.849328,"median":-25.139096,"eighty":65.320437,"marketCap":4172566121},{"date":"2022-09-09","current":-26.523099,"twenty":-62.849328,"median":-25.306228,"eighty":65.320437,"marketCap":4082594502},{"date":"2022-09-16","current":-23.786207,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3661315630},{"date":"2022-09-23","current":-21.269366,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3273908425},{"date":"2022-09-30","current":-22.727208,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3498308227},{"date":"2022-10-07","current":-21.743852,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3346944210},{"date":"2022-10-14","current":-22.018917,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3389283795},{"date":"2022-10-21","current":-22.961013,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3534296874},{"date":"2022-10-28","current":-24.666413,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3796802302},{"date":"2022-11-04","current":-23.35298,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3594630783},{"date":"2022-11-11","current":-23.71744,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3650730733},{"date":"2022-11-18","current":-21.124957,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3251680143},{"date":"2022-11-25","current":-20.28601,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3122544408},{"date":"2022-12-02","current":-20.428904,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3596774147},{"date":"2022-12-09","current":-18.207193,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3205613033},{"date":"2022-12-16","current":-19.12839,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3367801787},{"date":"2022-12-23","current":-23.060036,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":4060019152},{"date":"2022-12-30","current":-24.420759,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":4299592084},{"date":"2023-01-06","current":-22.506114,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3962493888},{"date":"2023-01-13","current":-22.168943,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3903130684},{"date":"2023-01-20","current":-20.326549,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3578753174},{"date":"2023-01-27","current":-20.236235,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3562852316},{"date":"2023-02-03","current":-22.267052,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3920403974},{"date":"2023-02-10","current":-23.21593,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3587232598},{"date":"2023-02-17","current":-23.657537,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3655468001},{"date":"2023-02-24","current":-22.872457,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3534160618},{"date":"2023-03-03","current":-22.676187,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3503833773},{"date":"2023-03-10","current":-18.442364,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2849640388},{"date":"2023-03-17","current":-17.033427,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2631936960},{"date":"2023-03-24","current":-17.026417,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2630853859},{"date":"2023-03-31","current":-17.804487,"twenty":-62.849328,"median":-25.329281,"eighty":65.318147,"marketCap":2751078140},{"date":"2023-04-06","current":-17.713362,"twenty":-62.849328,"median":-25.329281,"eighty":65.318147,"marketCap":2736997819},{"date":"2023-04-14","current":-21.379404,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3303459971},{"date":"2023-04-21","current":-20.972845,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3240640076},{"date":"2023-04-28","current":-24.505704,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3786523298},{"date":"2023-05-05","current":-28.503078,"twenty":-62.849328,"median":-25.406021,"eighty":65.320437,"marketCap":4281361861},{"date":"2023-05-12","current":-28.524429,"twenty":-62.849328,"median":-25.564592,"eighty":65.322728,"marketCap":4284568873},{"date":"2023-05-19","current":-25.820017,"twenty":-62.849328,"median":-25.767729,"eighty":65.327309,"marketCap":3878347273},{"date":"2023-05-26","current":-23.891344,"twenty":-62.849498,"median":-25.820017,"eighty":65.341771,"marketCap":3588647132},{"date":"2023-06-02","current":-24.6742,"twenty":-62.849668,"median":-25.85766,"eighty":65.356234,"marketCap":3706237596},{"date":"2023-06-09","current":-25.407238,"twenty":-62.849668,"median":-25.915884,"eighty":65.356234,"marketCap":3816345029},{"date":"2023-06-16","current":-25.435706,"twenty":-62.849668,"median":-25.915884,"eighty":65.356234,"marketCap":3820621046},{"date":"2023-06-23","current":-25.300485,"twenty":-62.849839,"median":-25.72783,"eighty":65.370696,"marketCap":3800309966},{"date":"2023-06-30","current":-25.570926,"twenty":-62.850009,"median":-25.674346,"eighty":65.385159,"marketCap":3840932126},{"date":"2023-07-07","current":-24.581681,"twenty":-62.850179,"median":-25.548283,"eighty":65.399621,"marketCap":3692340541},{"date":"2023-07-14","current":-24.546097,"twenty":-62.853133,"median":-25.4286,"eighty":65.437987,"marketCap":3686995520},{"date":"2023-07-21","current":-24.780953,"twenty":-62.853133,"median":-25.333526,"eighty":65.437987,"marketCap":3722272659},{"date":"2023-07-28","current":-25.499758,"twenty":-62.853133,"median":-25.303356,"eighty":65.437987,"marketCap":3830242084},{"date":"2023-08-04","current":-23.001735,"twenty":-62.853133,"median":-25.189784,"eighty":65.437987,"marketCap":3455021606},{"date":"2023-08-11","current":-17.14665,"twenty":-62.853133,"median":-25.145063,"eighty":65.437987,"marketCap":3105378341},{"date":"2023-08-18","current":-17.176244,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":3110737987},{"date":"2023-08-25","current":-16.596205,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":3005688944},{"date":"2023-09-01","current":-16.359455,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":2962811783},{"date":"2023-09-08","current":-17.886495,"twenty":-62.853133,"median":-25.073568,"eighty":65.437987,"marketCap":3239369468},{"date":"2023-09-15","current":-18.075895,"twenty":-62.856087,"median":-25.01581,"eighty":65.476352,"marketCap":3273671196},{"date":"2023-09-22","current":-16.116786,"twenty":-62.856087,"median":-24.951758,"eighty":65.476352,"marketCap":2918862694},{"date":"2023-09-29","current":-15.939223,"twenty":-62.856087,"median":-24.830151,"eighty":65.476352,"marketCap":2886704823},{"date":"2023-10-06","current":-15.122434,"twenty":-62.859042,"median":-24.823525,"eighty":65.514718,"marketCap":2738778620},{"date":"2023-10-13","current":-15.317753,"twenty":-62.859042,"median":-24.823525,"eighty":65.514718,"marketCap":2774152277},{"date":"2023-10-20","current":-15.004059,"twenty":-62.861996,"median":-24.825913,"eighty":65.553083,"marketCap":2717340040},{"date":"2023-10-23","current":-15.057327,"twenty":-62.861996,"median":-24.825913,"eighty":65.553083,"marketCap":2726987401},{"date":"2023-11-03","current":-15.483478,"twenty":-62.913621,"median":-24.830151,"eighty":65.661983,"marketCap":2804166290},{"date":"2023-11-10","current":-15.826766,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2866338172},{"date":"2023-11-17","current":-15.424291,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2793447000},{"date":"2023-11-24","current":-17.235431,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":3121457277},{"date":"2023-12-01","current":-11.082764,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2275014400},{"date":"2023-12-08","current":-12.837959,"twenty":-62.897398,"median":-24.823525,"eighty":65.638472,"marketCap":2635312111},{"date":"2023-12-15","current":-14.941857,"twenty":-62.897398,"median":-24.799067,"eighty":65.638472,"marketCap":3067189595},{"date":"2023-12-22","current":-15.051762,"twenty":-62.897398,"median":-24.799067,"eighty":65.638472,"marketCap":3089750359},{"date":"2023-12-29","current":-16.224082,"twenty":-62.913621,"median":-24.810593,"eighty":65.661983,"marketCap":3330398510},{"date":"2024-01-05","current":-20.727623,"twenty":-62.929845,"median":-24.815865,"eighty":65.685495,"marketCap":4254862911},{"date":"2024-01-12","current":-22.510451,"twenty":-62.929845,"median":-24.780146,"eighty":65.685495,"marketCap":4620832875},{"date":"2024-01-19","current":-19.905242,"twenty":-62.946069,"median":-24.739411,"eighty":65.709006,"marketCap":4086048483},{"date":"2024-01-26","current":-20.061314,"twenty":-62.929845,"median":-24.737541,"eighty":65.685495,"marketCap":4118086258},{"date":"2024-02-02","current":-19.419562,"twenty":-62.929845,"median":-24.715611,"eighty":65.685495,"marketCap":3986350531},{"date":"2024-02-09","current":-12.877492,"twenty":-62.929845,"median":-24.670306,"eighty":65.685495,"marketCap":3822219796},{"date":"2024-02-16","current":-12.343191,"twenty":-62.929845,"median":-24.583754,"eighty":65.685495,"marketCap":3663631746},{"date":"2024-02-23","current":-12.606167,"twenty":-62.929845,"median":-24.5259,"eighty":65.685495,"marketCap":3741686802},{"date":"2024-03-01","current":-13.39927,"twenty":-62.849839,"median":-24.403759,"eighty":65.661983,"marketCap":3977090939},{"date":"2024-03-08","current":-13.858435,"twenty":-62.78865,"median":-24.183136,"eighty":65.661983,"marketCap":4113377544},{"date":"2024-03-15","current":-11.445732,"twenty":-62.78865,"median":-24.078666,"eighty":65.661983,"marketCap":3397253381},{"date":"2024-03-22","current":-11.783844,"twenty":-62.78865,"median":-23.934586,"eighty":65.661983,"marketCap":3497609882},{"date":"2024-03-28","current":-11.980033,"twenty":-62.78865,"median":-23.867826,"eighty":65.661983,"marketCap":3555841431},{"date":"2024-04-05","current":-10.898908,"twenty":-62.771965,"median":-23.697907,"eighty":65.685495,"marketCap":3234948424},{"date":"2024-04-12","current":-10.719416,"twenty":-62.450545,"median":-23.597561,"eighty":65.685495,"marketCap":3181672751},{"date":"2024-04-19","current":-9.437928,"twenty":-62.450545,"median":-23.514443,"eighty":65.685495,"marketCap":2801309225},{"date":"2024-04-26","current":-9.129035,"twenty":-62.427752,"median":-23.37361,"eighty":65.661983,"marketCap":2709625509},{"date":"2024-05-03","current":-10.072411,"twenty":-62.427752,"median":-23.21593,"eighty":65.661983,"marketCap":2989632534},{"date":"2024-05-10","current":-6.482305,"twenty":-62.427752,"median":-23.186475,"eighty":65.370696,"marketCap":3068567760},{"date":"2024-05-17","current":-6.595323,"twenty":-62.427752,"median":-23.186475,"eighty":64.679241,"marketCap":3105005750},{"date":"2024-05-24","current":-6.508265,"twenty":-62.427752,"median":-23.186475,"eighty":63.492771,"marketCap":3064019674},{"date":"2024-05-31","current":-6.009659,"twenty":-62.427752,"median":-23.186475,"eighty":62.516156,"marketCap":2829281239},{"date":"2024-06-07","current":-6.513541,"twenty":-62.427752,"median":-23.186475,"eighty":61.77678,"marketCap":3066503678},{"date":"2024-06-14","current":-6.991043,"twenty":-62.450545,"median":-23.188804,"eighty":61.001953,"marketCap":3291306095},{"date":"2024-06-21","current":-6.27611,"twenty":-62.473339,"median":-23.191133,"eighty":60.436538,"marketCap":2954723471},{"date":"2024-06-28","current":-6.777354,"twenty":-62.570212,"median":-23.208812,"eighty":59.933947,"marketCap":3190703908},{"date":"2024-07-05","current":-6.61379,"twenty":-62.570212,"median":-23.208812,"eighty":58.878506,"marketCap":3113699766},{"date":"2024-07-12","current":-7.452716,"twenty":-62.570212,"median":-23.208812,"eighty":57.044321,"marketCap":3508656497},{"date":"2024-07-15","current":-7.415782,"twenty":-62.570212,"median":-23.208812,"eighty":56.809508,"marketCap":3491268465},{"date":"2024-08-02","current":-7.244303,"twenty":-62.781052,"median":-23.464332,"eighty":50.761782,"marketCap":3410538315},{"date":"2024-08-09","current":-5.966088,"twenty":-62.781052,"median":-23.464332,"eighty":47.94868,"marketCap":3213549832},{"date":"2024-08-16","current":-5.229847,"twenty":-62.781052,"median":-23.464332,"eighty":-5.237233,"marketCap":2816984108},{"date":"2024-08-23","current":-5.624509,"twenty":-62.781052,"median":-23.464332,"eighty":-5.400175,"marketCap":3029563227},{"date":"2024-08-30","current":-5.557578,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2993511797},{"date":"2024-09-06","current":-5.366017,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2890330120},{"date":"2024-09-13","current":-4.670166,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2515519569},{"date":"2024-09-20","current":-4.879037,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2628024892},{"date":"2024-09-27","current":-4.528226,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2439065675},{"date":"2024-10-04","current":-4.350513,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2343342914},{"date":"2024-10-11","current":-4.085097,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2200380349},{"date":"2024-10-18","current":-4.809798,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2590730310},{"date":"2024-10-25","current":-4.599773,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2477603410},{"date":"2024-10-31","current":-4.548998,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2450254050},{"date":"2024-11-08","current":-4.936736,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2659103710},{"date":"2024-11-15","current":-4.941352,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2661590016},{"date":"2024-11-22","current":-4.218959,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2272483208},{"date":"2024-11-29","current":-5.402946,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":3239028525},{"date":"2024-12-06","current":-4.628725,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2774888056},{"date":"2024-12-13","current":-4.595514,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2754978545},{"date":"2024-12-20","current":-4.04754,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2426471619},{"date":"2024-12-27","current":-4.053767,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2430204652},{"date":"2025-01-03","current":-4.078674,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2445136785},{"date":"2025-01-10","current":-4.099431,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2457580229},{"date":"2025-01-17","current":-3.947908,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2366743086},{"date":"2025-01-24","current":-4.468899,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2679073536},{"date":"2025-01-31","current":-4.199063,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2517308761},{"date":"2025-02-07","current":-4.27277,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2561495982},{"date":"2025-02-14","current":-3.766894,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2409734901},{"date":"2025-02-21","current":-4.131559,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2643016406},{"date":"2025-02-28","current":-3.733384,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2388298222},{"date":"2025-03-07","current":-3.483047,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":2228153621},{"date":"2025-03-14","current":-2.970544,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1900298532},{"date":"2025-03-21","current":-2.978429,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1905342457},{"date":"2025-03-28","current":-2.720206,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1740153931},{"date":"2025-04-04","current":-2.377224,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1520743218},{"date":"2025-04-11","current":-2.189963,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":1400950013},{"date":"2025-04-17","current":-2.237271,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":1431213559},{"date":"2025-04-21","current":-2.215588,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1417342767}],"updateTime":1745314821422}}}